UP

US approves new drug to treat Alzheimer's disease

Home page Science
12 Punto 14 Punto 16 Punto 18 Punto
US approves new drug to treat Alzheimer's disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

Axar.az reports the FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticised in a congressional report for its green-lighting of another Alzheimer's drug, Aduhelm.

And it was granted despite trial results showing the monoclonal antibody treatment carries risks of brain swelling and bleeding.

Both drugs were approved through an accelerated process that allows the FDA to fast-track approval of drugs for serious conditions where there is an unmet medical need.

Date
2023.01.07 / 11:38
Author
Axar.az
See also

Russia shot down 1,336 Ukrainian drones overnight

NASA's Voyager 1 set for historic distance milestone

Georgia to skip EU enlargement forum in Brussels

Prince and Princess of Wales arrive in India

Jensen Huang discusses comeback as Nvidia CEO with allies

AZAL to move all Baku-Istanbul flights to Istanbul Airport

Next civil society talks of Baku-Yerevan set for year-end

Nations League group stage enters final round

11 killed in southern Thailand building fire

Crimean bridge hit in Ukrainian strike - Video

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla